Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (2)
  • 2024 (5)
  • 2023 (5)
  • 2022 (4)
  • 2021 (9)
  • 2019 (4)

Subject

  • Prescription Drugs (14)
  • Diversion Division (9)
  • Drug Trafficking (7)
  • Pharmaceuticals/Pharmacists/Physicians (7)
  • Synthetic drugs (5)
  • Arrests/Convictions - Major (3)
  • Guns/Weapons (3)
  • Overdose (3)
  • Seizures (Drugs/Property) (3)
  • Major Law Enforcement Operation (2)
  • OCDETF/Task Force (2)
  • Outreach/Drug Prevention (2)
  • Task Forces/Task Force Officers (2)
  • Fake Pills (1)
  • Guilty Plea (1)
  • Money Laundering (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Public and Media Affairs - also see Congressional Affairs (1)

Drug Name

  • Fentanyl (2558)
  • Methamphetamine (2113)
  • Cocaine (1910)
  • Heroin (1176)
  • Marijuana (Cannabis) (339)
  • Oxycodone (279)
  • Synthetic Opioids (150)
  • Opioids (120)
  • Ecstasy/MDMA (51)
  • Hydromorphone (40)
  • Morphine (21)
  • Amphetamines (19)
  • Steroids (18)
  • Ketamine (15)
  • Marijuana Concentrates (14)
  • Methadone (13)
  • Xylazine (12)
  • K2/Spice (11)
  • LSD (11)
  • Synthetic Bath Salts or Designer Cathinones (5)
  • GHB (2)
  • Barbiturates (1)
  • Peyote & Mescaline (1)
  • Benzodiazepines (25)
  • Psilocybin (5)

Field Division

  • Washington, DC (6)
  • Seattle (5)
  • Atlanta (3)
  • New England (3)
  • St. Louis (3)
  • Miami (2)
  • New York (2)
  • El Paso (1)
  • Houston (1)
  • Los Angeles (1)
  • Phoenix (1)
  • Rocky Mountain (1)
  • Sede (1)
Clear All Results
30 Results - Showing 11 to 20
PRESS RELEASE

Former University of Arizona Student Sentenced to 84 Months in Prison for Drug Trafficking and Firearms Offenses

TUCSON, Ariz. – Jonathan Edward Mayer, 22, of Tacoma, Washington, was sentenced on June 30, 2023, by U.S. District Judge Scott H. Rash to 84 months in prison. Mayer previously pleaded guilty to Conspiracy to Possess with Intent to Distribute Marijuana, Possession with Intent to Distribute Marijuana, Possession of a...
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
PRESS RELEASE

Jamestown Man Pleads Guilty to Drug Conspiracy

ROCHESTER, N.Y.-U.S. Attorney Trini E. Ross announced today that Richard A. Philbrick, 37, of Jamestown, NY, pleaded guilty before U.S. District Judge Lawrence J. Vilardo to conspiracy to possess with intent to distribute, and to distribute, 400 grams or more fentanyl. The charges carry a mandatory minimum penalty of 10...
PRESS RELEASE

St. Augustine Doctor Indicted for Distributing Controlled Substances

JACKSONVILLE, Fla. – United States Attorney Roger B. Handberg announced the return of an indictment charging Scott Andrew Hollington, M.D. (57, St. Augustine) with 10 counts of distribution of controlled substances and one (1) count of conspiracy to distribute controlled substances. If convicted, Hollington faces a maximum penalty of 20...
PRESS RELEASE

Pill Mill Operator Convicted for Oxycodone Diversion

NEW YORK - Damian Williams, the United States Attorney for the Southern District of New York, announced that a jury returned a guilty verdict yesterday against Purificacion Cristobal for her participation in a conspiracy to distribute oxycodone without a legitimate medical purpose acting outside the usual course of professional practice...
PRESS RELEASE

Former Oregon Dentist Pleads Guilty in Federal Drug Case

PORTLAND, Ore.—A former Clackamas, Oregon dentist pleaded guilty today to illegally distributing controlled substances, including prescription drugs, and anabolic steroids. Salwan Wesam Adjaj, 43, a resident of West Linn, Oregon, waived indictment and pleaded guilty to a one-count information charging him with distributing and possessing with intent to distribute controlled...
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
PRESS RELEASE

DEA Washington Chief Issues Public Safety Alert: Dangerous Increase in Fake Rx Pills Containing Fentanyl

Washington, D.C. – Today, Jarod Forget, Special Agent in Charge of the DEA Washington Division issued a Public Safety Alert warning Maryland, Virginia, and Washington, D.C. residents of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl in our area. This DEA Public Safety Alert...
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Current page 2
  • Page 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster